The SIRT1/STAT3 axis as a central regulator of immune, inflammatory, and lipid metabolic dysregulation in rheumatoid arthritis: therapeutic implications - Takeaways - MDSpire

The SIRT1/STAT3 axis as a central regulator of immune, inflammatory, and lipid metabolic dysregulation in rheumatoid arthritis: therapeutic implications

  • By

  • Chengzhi Cong

  • Yuan Wang

  • Jian Liu

  • June 2, 2026

  • 0 min

Share

  • 1

    Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation and systemic comorbidities, particularly cardiovascular disease.

  • 2

    The SIRT1/STAT3 axis is proposed as a central regulator of immune, inflammatory, and lipid metabolic dysregulation in RA.

  • 3

    SIRT1 acts as an anti-inflammatory metabolic sensor, while STAT3 serves as a proinflammatory transcription factor driving immune responses.

  • 4

    Chronic inflammation in RA suppresses SIRT1 and hyperactivates STAT3, creating a feedback loop that perpetuates immune imbalance.

  • 5

    Therapeutic strategies targeting the SIRT1/STAT3 axis, including SIRT1 activators and STAT3 inhibitors, may improve RA treatment outcomes.

Original Source(s)

The SIRT1/STAT3 axis as a central regulator of immune, inflammatory, and lipid metabolic dysregulation in rheumatoid arthritis: therapeutic implications

  • by Chengzhi Cong, Yuan Wang, Jian Liu

  • June 2, 2026

Related Content

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains

An explainable predictive machine learning model of osteopenia for perimenopausal women based on clinical data: a retrospective single-center study

Swimming ameliorates intervertebral disc degeneration accompanied by Rpl23a downregulation and changes in its immune-inflammatory pathway